The crystal structure of AbsH3: A putative flavin adenine dinucleotide-dependent reductase in the abyssomicin biosynthesis pathway

Jonathan A. Clinger, Xiachang Wang, Wenlong Cai, Yanyan Zhu, Mitchell D. Miller, Chang Guo Zhan, Steven G. Van Lanen, Jon S. Thorson, George N. Phillips

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

Natural products and natural product-derived compounds have been widely used for pharmaceuticals for many years, and the search for new natural products that may have interesting activity is ongoing. Abyssomicins are natural product molecules that have antibiotic activity via inhibition of the folate synthesis pathway in microbiota. These compounds also appear to undergo a required [4 + 2] cycloaddition in their biosynthetic pathway. Here we report the structure of an flavin adenine dinucleotide-dependent reductase, AbsH3, from the biosynthetic gene cluster of novel abyssomicins found in Streptomyces sp. LC-6-2.

Original languageEnglish
Pages (from-to)132-137
Number of pages6
JournalProteins: Structure, Function and Bioinformatics
Volume89
Issue number1
DOIs
StatePublished - Jan 2021

Bibliographical note

Publisher Copyright:
© 2020 Wiley Periodicals LLC.

Funding

This work was supported by the Protein Structure Initiative project, Enzyme Discovery for Natural Product Biosynthesis (NATPRO) with NIH/NIGMS Grant number: U01GM098248, as well as NIH grants R01 CA217255 and R01 GM115261. This work was partially supported by a training fellowship for Jonathan Clinger from the Keck Center of the Gulf Coast Consortia, as part of the Houston Area Molecular Biophysics Program, National Institute of General Medical Sciences (NIGMS) T32GM008280. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. This work was supported by the Protein Structure Initiative project, Enzyme Discovery for Natural Product Biosynthesis (NATPRO) with NIH/NIGMS Grant number: U01GM098248, as well as NIH grants R01 CA217255 and R01 GM115261. This work was partially supported by a training fellowship for Jonathan Clinger from the Keck Center of the Gulf Coast Consortia, as part of the Houston Area Molecular Biophysics Program, National Institute of General Medical Sciences (NIGMS) T32GM008280. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE‐AC02‐06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL‐CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.

FundersFunder number
Enzyme Discovery for Natural Product Biosynthesis
Keck Center of the Gulf Coast Consortia, as part of the Houston Area Molecular Biophysics Program
Lilly Research Laboratories
Protein Structure Initiative NatPro Project
National Institutes of Health (NIH)R01 GM115261
Michigan State University-U.S. Department of Energy (MSU-DOE) Plant Research Laboratory
National Childhood Cancer Registry – National Cancer InstituteR01CA217255
National Institute of General Medical SciencesU01GM098248, T32GM008280
Eli Lilly and Company
Office of Science Programs
Argonne National LaboratoryDE‐AC02‐06CH11357

    Keywords

    • X-ray crystallography
    • antibiotics
    • ice rings
    • natural product
    • oxidoreductase

    ASJC Scopus subject areas

    • Structural Biology
    • Biochemistry
    • Molecular Biology

    Fingerprint

    Dive into the research topics of 'The crystal structure of AbsH3: A putative flavin adenine dinucleotide-dependent reductase in the abyssomicin biosynthesis pathway'. Together they form a unique fingerprint.

    Cite this